Neem

Metadata

Approved Indications

Commission E (Germany)

• No Commission E monograph exists for neem

ESCOP

• No ESCOP monograph has been published for neem

EMA/HMPC (European Medicines Agency)

• No EMA/HMPC monograph exists for neem
• Neem is not part of the European phytotherapy tradition and has no regulatory history in the EU as a medicinal product

WHO Monographs on Selected Medicinal Plants

• WHO has included neem leaf (Folium Azadirachtae) in its monographs series
• The WHO monograph documents traditional uses including treatment of skin diseases, malaria, diabetes, and as an antimicrobial and anti-inflammatory agent

Ayurvedic Pharmacopoeia of India

• Neem is officially listed in the Ayurvedic Pharmacopoeia of India
• Traditional indications include skin diseases (kushtha), blood impurities (rakta shodhana), fever (jwara), worm infestation (krimi), and diabetes (prameha)

Agreement/Disagreement Between Bodies

• No European regulatory body has issued a therapeutic monograph for neem
• There is a significant gap between the extensive Ayurvedic documentation and the absence of Western regulatory recognition
• WHO recognition bridges this gap somewhat by documenting traditional uses in a standardized format
• The lack of European monographs reflects the limited Western clinical trial evidence rather than a negative assessment of neem’s pharmacological properties

Conditions Treated

Primary (Strong Traditional Evidence, Limited Clinical Data)

• Skin diseases: Eczema, psoriasis, acne, fungal infections, scabies — the most prominent traditional use; supported by in vitro antimicrobial and anti-inflammatory data and limited clinical studies
• Oral health: Gingivitis, dental plaque, periodontal disease — neem twig chewing sticks are used by hundreds of millions across South Asia; some clinical studies support antibacterial effects against oral pathogens

Secondary (Traditional Use with Preclinical Support)

• Antimicrobial / Antiseptic: Broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses demonstrated in vitro
• Anti-inflammatory: Nimbidin and other compounds show anti-inflammatory activity in animal models
• Wound healing: Traditional topical application for minor wounds; supported by animal studies

Traditional/Historical (Limited Evidence)

• Malaria and fever (traditional use in endemic regions; some preclinical antimalarial activity)
• Diabetes and blood sugar regulation (Ayurvedic tradition; limited clinical data with mixed results)
• Blood purification (rakta shodhana in Ayurveda)
• Intestinal worms and parasites (traditional anthelmintic use)
• Insect repellent and pesticide (well-established non-medicinal use)
• Liver protection (preclinical data only)
• Contraceptive effects (preclinical data on neem oil; not recommended for this purpose)

Mechanism of Action

Primary Mechanisms

Antimicrobial:

• Azadirachtin, nimbolide, and nimbidin demonstrate broad-spectrum antibacterial activity against Gram-positive and Gram-negative organisms
• Antifungal activity is documented against dermatophytes, Candida species, and Aspergillus species
• Mechanisms include disruption of cell membrane integrity, inhibition of biofilm formation, and interference with microbial enzyme systems

Anti-inflammatory / Immunomodulatory:

• Nimbidin inhibits complement activation and reduces macrophage-mediated inflammation
• Nimbolide suppresses NF-kB signaling and reduces pro-inflammatory cytokine production (TNF-alpha, IL-1, IL-6)
• Limonoids (gedunin and related compounds) modulate immune cell function

Secondary Mechanisms

Unique Pharmacological Profile

• Neem is notable for the sheer breadth of bioactive compounds identified (over 300 secondary metabolites)
• The limonoid class (azadirachtin, nimbin, nimbolide, gedunin, salannin) is relatively unique to the Meliaceae family and accounts for many of neem’s distinctive biological activities
• The insecticidal properties of azadirachtin are among the most thoroughly studied of any botanical compound

Clinical Evidence Summary

Volume of Evidence

• Limited by Western clinical trial standards. The vast majority of evidence comes from in vitro studies, animal models, and traditional use documentation. Clinical studies that do exist are mostly small, often uncontrolled, and primarily conducted in India.

Key Studies

Dermatological

Oral Health

Diabetes (Exploratory)

• A small number of clinical studies have examined neem leaf extract for blood sugar regulation with mixed and inconclusive results
• This indication remains exploratory and cannot be recommended on current evidence

Evidence Gaps

• No large, well-designed RCTs for any dermatological indication
• No standardized extract has undergone rigorous clinical development
• No dose-response studies in humans
• No long-term safety data from clinical trials
• Pharmacokinetic data in humans is essentially absent
• Head-to-head comparisons with standard treatments are lacking

European vs US/Anglophone Consensus

Safety Profile

Contraindications

• Known hypersensitivity to neem or Meliaceae family plants
• Children (especially infants and young children) — neem oil ingestion can cause serious adverse effects
• Severe hepatic or renal impairment
• Pregnancy (see below)
• Autoimmune diseases (theoretical immunostimulant concerns)

Drug Interactions

• No clinically documented drug interactions at standard doses
• Theoretical interactions with antidiabetic medications (additive hypoglycemic effect)
• Theoretical interactions with immunosuppressant medications (neem may have immunostimulant properties)
• Insufficient pharmacokinetic data to assess CYP enzyme interactions

Side Effects

• Neem leaf preparations (oral): Generally well tolerated in short-term use at traditional doses; occasional gastrointestinal discomfort (nausea, loose stool)
• Neem oil (oral ingestion): POTENTIALLY TOXIC — neem oil ingestion has been associated with serious adverse effects including vomiting, metabolic acidosis, encephalopathy, and hepatotoxicity, particularly in children. Several fatalities in children have been reported in the Indian medical literature
• Neem oil (topical): Generally safe for topical use; contact dermatitis is rare but possible. Patch testing recommended for first use
• Long-term use: Chronic oral use of neem extracts may potentially cause renal dysfunction, hypotension, and hypoglycemia based on animal data; long-term human safety data is lacking

Pregnancy/Lactation

• Contraindicated in pregnancy: Neem has demonstrated abortifacient and anti-implantation effects in animal studies; neem oil and bark extracts have traditional anti-fertility uses
• Lactation: Insufficient safety data; not recommended during breastfeeding
• Fertility: Neem oil has demonstrated reversible anti-fertility effects in animal models; relevance to human fertility at standard doses is uncertain but warrants caution

Clinical Dosage

Standard Dosage Forms

Ayurvedic Dosage (Traditional)

• Neem leaf juice (swarasa): 10-20 mL daily
• Neem leaf powder (churna): 1-3 g daily
• Neem bark decoction (kwatha): 50-100 mL daily
• Duration varies by indication; typically used in courses of 2-8 weeks in Ayurvedic practice

Important Safety Note

• Neem oil must NOT be taken internally — serious toxicity has been reported, particularly in children
• All oral dosage recommendations refer to leaf, bark, or flower preparations, not to neem seed oil

Sources

• WHO Monographs on Selected Medicinal Plants, Vol. 3: Folium Azadirachtae indicae
• Subapriya R, Nagini S. Medicinal properties of neem leaves: a review. Curr Med Chem Anticancer Agents. 2005;5(2):149-156
• Biswas K, et al. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci. 2002;82(11):1336-1345
• Alzohairy MA. Therapeutics role of Azadirachta indica (neem) and their active constituents in diseases prevention and treatment. Evid Based Complement Alternat Med. 2016;2016:7382506
• Chatterjee A, et al. Evaluation of the anti-plaque effectiveness of neem (Azadirachta indica) extract as an adjunct to mechanical plaque control. Indian J Dent Res. 2011;22(1):140
• Balappanavar AY, et al. Comparison of the effectiveness of 0.5% tea, 2% neem and 0.2% chlorhexidine mouthwashes on oral health: a randomized control trial. Indian J Dent Res. 2013;24(1):26-34
• Abdel-Ghaffar F, Semmler M. Efficacy of neem seed extract shampoo on head lice of naturally infected humans. Parasitol Res. 2007;100(2):329-332
• Ayurvedic Pharmacopoeia of India, Part I, Vol. 1-6 (Government of India, Ministry of AYUSH)
• Sinniah D, Baskaran G. Margosa oil poisoning as a cause of Reye’s syndrome. Lancet. 1981;1(8218):487-489

Connections

• Compare with Tea Tree as another potent antimicrobial botanical used topically for skin conditions; tea tree oil has stronger Western clinical evidence and regulatory documentation
• Related to Calendula as a traditional wound-healing and skin-care herb; calendula has Commission E approval and ESCOP documentation
• Compare with Aloe Vera for topical skin applications; aloe has broader Western clinical evidence and regulatory recognition
• Related to Moringa as a multi-purpose tree widely used in traditional medicine across tropical regions, with broad pharmacological activity but limited Western clinical trial evidence